XTL Biopharmaceuticals acquires 85% of Beyond Air's NeuroNOS subsidiary
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- S&P 500, Nasdaq set for higher open as SK Hynix lifts chips; Fed in focus
- SK Hynix shares surge after Q3 profit beats expectations
- Oil up 1% as Saudi Arabian refinery attack reignites supply concerns
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| (NASDAQ: XAIR) | Delayed: 2.22 +0.01 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.21 | 52 Week High | $ | |||
| Open | $2.24 | 52 Week Low | $ | |||
| Day High | $2.24 | P/E | N/A | |||
| Day Low | $2.22 | EPS | $ | |||
| Volume | 1,686 | |||||
| XTL BIOPHARM SP ADR (NASDAQ: XTLB) | Delayed: 1.78 -0.03 (1.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.81 | 52 Week High | $1.75 | |||
| Open | $1.78 | 52 Week Low | $0.64 | |||
| Day High | $1.78 | P/E | N/A | |||
| Day Low | $1.78 | EPS | $0.00 | |||
| Volume | 158 | |||||
